What is Sentrian?
Sentrian operates as a health blog, dedicated to furnishing readers with comprehensive health and fitness insights. The company's core mission revolves around empowering individuals to lead healthier, happier lives through well-researched, unbiased news, tips, and advice. Sentrian targets a broad audience interested in enhancing their well-being via scientifically grounded information, positioning itself as a trusted source in the digital health and wellness space.
How much funding has Sentrian raised?
Sentrian has raised a total of $15.8M across 2 funding rounds:
Angel/Seed
$3.8M
Series A
$12M
Angel/Seed (2012): $3.8M with participation from Frost Data Capital and Reed Elsevier Ventures
Series A (2014): $12M led by TELUS Corporation, Reed Elsevier Ventures, and Frost Data Capital
Key Investors in Sentrian
Frost Data Capital
Frost Data Capital is a venture capital firm specializing in building big data startups. They focus on identifying market gaps and collaborating with corporations to develop advanced big data technologies, particularly in sectors like online gaming, aiming to create personalized experiences and enhance security.
Reed Elsevier Ventures
Reed Elsevier Ventures is a London-based venture capital firm backed by Reed Elsevier. They invest in entrepreneurs with the vision to build great companies, taking an active role in their development and leveraging an extensive network of industry contacts.
TELUS Corporation
TELUS Corporation is a Canadian telecommunications and information technology company. They provide a wide range of products and services, indicating a strategic interest in Sentrian's potential for technological integration and data-driven health solutions.
What's next for Sentrian?
The substantial enterprise-level funding secured by Sentrian, particularly the Series A round in 2014, indicates a strategic pivot towards scaling operations and expanding its content reach. The involvement of TELUS Corporation, a major telecommunications and IT provider, alongside established venture capital firms like Frost Data Capital and Reed Elsevier Ventures, suggests a focus on leveraging technology and data analytics to enhance user experience and potentially explore new monetization avenues. This backing is poised to fuel Sentrian's expansion into new markets and further solidify its position as a leading health information platform.
See full Sentrian company page